PDF herunterladen
Appl Clin Inform 2014; 05(04): 895-906
DOI: 10.4338/ACI-2014-06-RA-0053
Research Article
Schattauer GmbH

A Survey of Nursing Home Physicians to Determine Laboratory Monitoring Adverse Drug Event Alert Preferences

R.D. Boyce
1   Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, PA
2   Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA
3   Geriatric Pharmaceutical Outcomes and Geroinformatics Research & Training Program, University of Pittsburgh, Pittsburgh, PA
,
S. Perera
4   Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
5   Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA.
,
D.A. Nace
4   Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
,
C.M. Culley
6   Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA.
,
S.M. Handler
1   Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, PA
2   Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, PA
3   Geriatric Pharmaceutical Outcomes and Geroinformatics Research & Training Program, University of Pittsburgh, Pittsburgh, PA
4   Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
7   Geriatric Research Education and Clinical Center (GRECC), Veterans Affairs Pittsburgh Healthcare System (VAPHS), Pittsburgh, PA
8   Center for Health Equity Research and Promotion (CHERP), VAPHS, Pittsburgh, PA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received: 13. Juni 2014

accepted: 03. Oktober 2014

Publikationsdatum:
19. Dezember 2017 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Summary

Objective: We conducted a survey of nursing home physicians to learn about (1) the laboratory value thresholds that clinical event monitors should use to generate alerts about potential adverse drug events (ADEs); (2) the specific information to be included in the alerts; and (3) the communication modality that should be used for communicating them.

Methods: Nursing home physician attendees of the 2010 Conference of AMDA: The Society for Post-Acute and Long-Term Care Medicine.

Results: A total of 800 surveys were distributed; 565 completed surveys were returned and seven surveys were excluded due to inability to verify that the respondents were physicians (a 70% net valid response rate). Alerting threshold preferences were identified for eight laboratory tests. For example, the majority of respondents selected thresholds of ≥ 5.5 mEq/L for hyperkalemia (63%) and ≤ 3.5 without symptoms for hypokalemia (54%). The majority of surveyed physicians thought alerts should include the complete active medication list, current vital signs, previous value of the triggering lab, medication change in the past 30 days, and medication allergies. Most surveyed physicians felt the best way to communicate an ADE alert was by direct phone/voice communication (64%), followed by email to a mobile device (59%).

Conclusions: This survey of nursing home physicians suggests that the majority prefer alerting thresholds that would generally lead to fewer alerts than if widely accepted standardized laboratory ranges were used. It also suggests a subset of information items to include in alerts, and the physicians’ preferred communication modalities. This information might improve the acceptance of clinical event monitoring systems to detect ADEs in the nursing home setting.

Citation: Boyce RD, Perera S, Nace DA, Culley CM, Handler SM. A survey of nursing home physicians to determine laboratory monitoring adverse drug event alert preferences. Appl Clin Inf 2014; 5: 895–906

http://dx.doi.org/10.4338/ACI-2014-06-RA-0053

Keywords

Nursing homes - therapeutic drug monitoring - clinical decision support systems - adverse drug event
 

  • References

  • 1 Institute of Medicine. To Err Is Human: Building a Safer Health System. Kohn L, Corrigan J, Donaldson M. editors. Washington, DC: National Academy Press; 2000
    Google Scholar
  • 2 Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997; 157 (18) 2089-2096.
    CrossrefPubMedGoogle Scholar
  • 3 Gurwitz JH, Field TS, Rochon P, Judge J, Harrold LR, Bell CM, Lee M, White K, LaPrino J, ErramuspeMainard J, DeFlorio M, Gavendo L, Baril JL, Reed G, Bates DW. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc 2008; 56 (12) 2225-2233.
    CrossrefPubMedGoogle Scholar
  • 4 Handler SM, Wright RM, Ruby CM, Hanlon JT. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006; 4 (03) 264-272.
    CrossrefPubMedGoogle Scholar
  • 5 Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109 (02) 87-94.
    CrossrefPubMedGoogle Scholar
  • 6 Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K, LaPrino J, ErramuspeMainard J, DeFlorio M, Gavendo L, Auger J, Bates DW. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005; 118 (03) 251-258.
    CrossrefPubMedGoogle Scholar
  • 7 Ouslander JG, Bonner A. SNFs: Opening the Black Box. Web M&M: Morbidity and Mortality Rounds on the Web. 2013. Available from: http://www.webmm.ahrq.gov/case.aspx?caseID=313. Last Accessed 8/27/2014.
    PubMedGoogle Scholar
  • 8 Harris-Kojetin L, Sengupta M, Park-Lee E, Valverde R. Long-Term Care Services inthe United States: 2013 Overview. Hyattsville, MD: National Center for Health Statistics,; 2013
    Google Scholar
  • 9 Castle NG, Engberg J, Men A. Nursing home staff turnover: impact on nursing home compare quality measures. Gerontologist 2007; 47 (05) 650-661.
    CrossrefPubMedGoogle Scholar
  • 10 Decker F, Gruhn P, Matthews-Martin L, Dollard K, Dollard Tucker A, Bizette L. Results of the 2002 AHCA Survey of Nursing Staff Vacancy and Turnover in Nursing Homes. American Health Care Association. 2003 February 12, 2003.
    PubMedGoogle Scholar
  • 11 Donoghue C. Nursing Home Staff Turnover and Retention An Analysis of National Level Data. J Appl Gerontol 2010; 29 (01) 89-106.
    CrossrefPubMedGoogle Scholar
  • 12 Handler S, Castle N, Studenski S, Perera S, Fridsma D, Nace D, Hanlon J. Patient safety culture assessment in the nursing home. Qual Saf Health Care 2006; 15 (06) 400-404.
    CrossrefPubMedGoogle Scholar
  • 13 Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266 (20) 2847-2851.
    CrossrefPubMedGoogle Scholar
  • 14 Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, Burdick E, Seger DL, Vander Vliet M, Bates DW. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5 (03) 305-314.
    CrossrefPubMedGoogle Scholar
  • 15 Honigman B, Lee J, Rothschild J, Light P, Pulling RM, Yu T, Bates DW. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001; 8 (03) 254-266.
    CrossrefPubMedGoogle Scholar
  • 16 Agency for Healthcare Research and Quality. Reducing and Preventing Adverse Drug Events To Decrease Hospital Costs. Rockville, MD: 2001 AHRQ Publication Number 01-0020.
    PubMedGoogle Scholar
  • 17 Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994; 28 (04) 523-527.
    CrossrefPubMedGoogle Scholar
  • 18 Hartis CE, Gum MO, Lederer Jr. JW. Use of specific indicators to detect warfarin-related adverse events. Am J Health Syst Pharm 2005; 62 (16) 1683-1688.
    CrossrefPubMedGoogle Scholar
  • 19 Jha AK, Laguette J, Seger A, Bates DW. Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application. J Am Med Inform Assoc 2008; 15 (05) 647-653.
    CrossrefPubMedGoogle Scholar
  • 20 Peterson JF, Williams DH, Seger A, Gandhi TK, Bates DW. Drug-lab triggers have the potential to prevent adverse drug events in outpatients. J Am Med Inform Assoc 2002; 9 (06) S39-S40.
    CrossrefPubMedGoogle Scholar
  • 21 Raschke RA, Gollihare B, Wunderlich TA, Guidry JR, Leibowitz AI, Peirce JC, Lemelson L, Heisler MA, Susong C. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998; 280 (15) 1317-1320.
    CrossrefPubMedGoogle Scholar
  • 22 Silverman JB, Stapinski CD, Huber C, Ghandi TK, Churchill WW. Computer-based system for preventing adverse drug events. Am J Health Syst Pharm 2004; 61 (15) 1599-1603.
    PubMedGoogle Scholar
  • 23 Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004; 13 (04) 306-314.
    CrossrefPubMedGoogle Scholar
  • 24 Levy M, Azaz-Livshits T, Sadan B, Shalit M, Geisslinger G, Brune K. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999; 54 (11) 887-892.
    CrossrefPubMedGoogle Scholar
  • 25 Murff HJ, Patel VL, Hripcsak G, Bates DW. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform 2003; 36 1–2 131-143.
    CrossrefPubMedGoogle Scholar
  • 26 Tegeder I, Levy M, Muth-Selbach U, Oelkers R, Neumann F, Dormann H, Azaz-Livshits T, Criegee-Rieck M, Schneider HT, Hahn E, Brune K, Geisslinger G. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol 1999; 47 (05) 557-564.
    PubMedGoogle Scholar
  • 27 Handler SM, Altman RL, Perera S, Hanlon JT, Studenski SA, Bost JE, Saul MI, Fridsma DB. A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting. J Am Med Inform Assoc 2007; 14 (04) 451-458.
    CrossrefPubMedGoogle Scholar
  • 28 Abramson EL, McGinnis S, Moore J, Kaushal R. investigators H. A statewide assessment of electronic health record adoption and health information exchange among nursing homes. Health Serv Res 2014; 49 1 Pt 2 361-372.
    CrossrefPubMedGoogle Scholar
  • 29 Martin CM. Getting ready for MDS 3.0: patient evaluation takes a new turn. Consult Phar 2010; 25 (07) 404-406 11-15.
    PubMedGoogle Scholar
  • 30 Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, Bates DW, Gurwitz JH. Prescribers’ responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc 2006; 13 (04) 385-390.
    CrossrefPubMedGoogle Scholar
  • 31 Rochon PA, Field TS, Bates DW, Lee M, Gavendo L, Erramuspe-Mainard J, Judge J, Gurwitz JH. Computerized physician order entry with clinical decision support in the long-term care setting: insights from the baycrest centre for geriatric care. J Am Geriatr Soc 2005; 53 (10) 1780-1789.
    CrossrefPubMedGoogle Scholar
  • 32 Kramer A, Richard AA, Epstein A, Winn D, May K. Understanding the costs and benefits of health information technology in nursing homes and home health agencies: case study findings. University of Colorado; Denver: 2009
    Google Scholar
  • 33 Handler SM, Hanlon JT, Perera S, Roumani YF, Nace DA, Fridsma DB, Saul MI, Castle NG, Studenski SA. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc 2008; 56 (05) 808-815.
    CrossrefPubMedGoogle Scholar
  • 34 Handler SM, Hanlon JT. Detecting Adverse Drug Events Using a Nursing Home Specific Trigger Tool. Ann Longterm Care 2010; 18 (05) 17-22.
    PubMedGoogle Scholar
  • 35 Handler SM, Hanlon JT, Perera S, Saul MI, Fridsma DB, Visweswaran S, Studenski SA, Roumani YF, Castle NG, Nace DA, Becich MJ. Assessing the performance characteristics of signals used by a clinical event monitor to detect adverse drug reactions in the nursing home. AMIA Annu Symp Proc 2008: 278-282.
    PubMedGoogle Scholar
  • 36 Gennari FJ. Hypokalemia. N Engl J Med 1998; 339 (07) 451-458.
    CrossrefPubMedGoogle Scholar
  • 37 Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123 (04) 1367-1384.
    CrossrefPubMedGoogle Scholar
  • 38 Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003; Jun 26 (06) 1902-12.
    CrossrefPubMedGoogle Scholar
  • 39 Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004; 351 (06) 585-592.
    CrossrefPubMedGoogle Scholar
  • 40 Holt MP, Ju C. Mechanisms of drug-induced liver injury. AAPS Journal 2006; 8 (01) E48-54.
    CrossrefPubMedGoogle Scholar
  • 41 Gurwitz JH, Field TS, Radford MJ, Harrold LR, Becker R, Reed G, DeBellis K, Moldoff J, Verzier N. The safety of warfarin therapy in the nursing home setting. Am J Med 2007; 120 (06) 539-544.
    CrossrefPubMedGoogle Scholar
  • 42 Levin A, Warnock DG, Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C. Acute Kidney Injury Network Working G. Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis 2007; 50 (01) 1-4.
    CrossrefPubMedGoogle Scholar
  • 43 Wallach JB. Interpretation of diagnostic tests. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Wiliams & Wilkins; 2007
    Google Scholar
  • 44 Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, American College of Chest P. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (06) Suppl 160S-98S.
    CrossrefPubMedGoogle Scholar
  • 45 National Cancer Institute.. Common Terminology Criteria for Adverse Events v4.0 National Institutes of Health, 2009 NIH publication # 09–7473
    PubMed
  • 46 Rose AJ, Ozonoff A, Berlowitz DR, Henault LE, Hylek EM. Warfarin dose management affects INR control. J Thromb Haemost 2009; 7 (01) 94-101.
    CrossrefPubMedGoogle Scholar
  • 47 Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values.[Erratum appears in N Engl J Med 2004; 351 (23) ): 2461. N Engl J Med. 2004; 351(15 1548-1563.
    PubMedGoogle Scholar
  • 48 Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) e152S-e184S.
    CrossrefPubMedGoogle Scholar
  • 49 Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, Nieuwlaat R, Souza NM, Beyene J, Van Spall HG, Garg AX, Haynes RB. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ 2013; 346: f657.
    CrossrefPubMedGoogle Scholar
  • 50 Garritty C, El Emam K. Who’s using PDAs? Estimates of PDA use by health care providers: a systematic review of surveys. J Med Internet Res 2006; 8 (02) e7.
    CrossrefPubMedGoogle Scholar
  • 51 Handler SM, Boyce RD, Ligons FM, Perera S, Nace DA, Hochheiser H. Use and perceived benefits of mobile devices by physicians in preventing adverse drug events in the nursing home. J Am Med Dir Assoc 2013; 14 (12) 906-910.
    CrossrefPubMedGoogle Scholar
  • 52 Boussadi A, Caruba T, Zapletal E, Sabatier B, Durieux P, Degoulet P. A clinical data warehouse-based process for refining medication orders alerts. J Am Med Inform Assoc 2012; 19 (05) 782-775.
    CrossrefPubMedGoogle Scholar